Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 25 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii.
Russo TA, Umland TC, Deng X, El Mazouni F, Kokkonda S, Olson R, Carlino-MacDonald U, Beanan J, Alvarado CL, Tomchick DR, Hutson A, Chen H, Posner B, Rathod PK, Charman SA, Phillips MA
Proc Natl Acad Sci U S A, 119(51):e2213116119, 13 Dec 2022
Cited by: 4 articles | PMID: 36512492 | PMCID: PMC9907071
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model.
Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Russo TA, Balthasar JP
J Pharmacol Exp Ther, 368(3):475-489, 03 Jan 2019
Cited by: 7 articles | PMID: 30606761
Add to export list
The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA
Infect Immun, 85(12):e00591-17, 17 Nov 2017
Cited by: 34 articles | PMID: 28947651 | PMCID: PMC5695103
Add to export list Free full text in Europe PMC
Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge.
Bulger J, MacDonald U, Olson R, Beanan J, Russo TA
Infect Immun, 85(10):e00093-17, 20 Sep 2017
Cited by: 51 articles | PMID: 28717029 | PMCID: PMC5607406
Add to export list Free full text in Europe PMC
The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.
Russo TA, Manohar A, Beanan JM, Olson R, MacDonald U, Graham J, Umland TC
mSphere, 1(3):e00082-16, 11 May 2016
Cited by: 58 articles | PMID: 27303741 | PMCID: PMC4888885
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.
Russo TA, Olson R, MacDonald U, Beanan J, Davidson BA
Infect Immun, 83(8):3325-3333, 08 Jun 2015
Cited by: 154 articles | PMID: 26056379 | PMCID: PMC4496593
Add to export list Free full text in Europe PMC
Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
Sutton KA, Breen J, MacDonald U, Beanan JM, Olson R, Russo TA, Schultz LW, Umland TC
Acta Crystallogr D Biol Crystallogr, 71(pt 8):1736-1744, 31 Jul 2015
Cited by: 5 articles | PMID: 26249354
Add to export list
In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.
Umland TC, Schultz LW, MacDonald U, Beanan JM, Olson R, Russo TA
mBio, 3(4):e00113-12, 31 Aug 2012
Cited by: 49 articles | PMID: 22911967 | PMCID: PMC3428692
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.
Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA
Infect Immun, 81(3):915-922, 07 Jan 2013
Cited by: 84 articles | PMID: 23297385 | PMCID: PMC3584894
Add to export list Free full text in Europe PMC
Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.
Kong Q, Beanan JM, Olson R, Macdonald U, Shon AS, Metzger DJ, Pomakov AO, Russo TA
Virulence, 3(3):309-318, 01 May 2012
Cited by: 14 articles | PMID: 22546898 | PMCID: PMC3442843
Add to export list Free full text in Europe PMC
Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.
Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP
PLoS One, 6(10):e26734, 24 Oct 2011
Cited by: 73 articles | PMID: 22039542 | PMCID: PMC3200348
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.
Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA
Eur J Clin Microbiol Infect Dis, 31(6):981-989, 15 Sep 2011
Cited by: 125 articles | PMID: 21918907
Add to export list
The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.
Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA
Infect Immun, 78(9):3993-4000, 19 Jul 2010
Cited by: 194 articles | PMID: 20643860 | PMCID: PMC2937447
Add to export list Free full text in Europe PMC
Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.
Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA
Infect Immun, 78(5):2017-2023, 01 Mar 2010
Cited by: 73 articles | PMID: 20194587 | PMCID: PMC2863528
Add to export list Free full text in Europe PMC
In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.
Russo TA, Page MG, Beanan JM, Olson R, Hujer AM, Hujer KM, Jacobs M, Bajaksouzian S, Endimiani A, Bonomo RA
J Antimicrob Chemother, 66(4):867-873, 13 Feb 2011
Cited by: 37 articles | PMID: 21393224 | PMCID: PMC3058568
Add to export list Free full text in Europe PMC
Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.
Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC
J Infect Dis, 199(4):513-521, 01 Feb 2009
Cited by: 71 articles | PMID: 19143563
Add to export list
Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.
Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA
Infect Immun, 76(8):3577-3586, 09 Jun 2008
Cited by: 44 articles | PMID: 18541654 | PMCID: PMC2493229
Add to export list Free full text in Europe PMC
Capsule and O-antigen from an extraintestinal isolate of Escherichia coli modulate cytokine levels in rat macrophages in vitro and in a rat model of pneumonia.
Russo TA, Davidson BA, Beanan JM, Olson R, Holm BA, Notter RH, Knight PR
Exp Lung Res, 33(7):337-356, 01 Sep 2007
Cited by: 2 articles | PMID: 17849261
Add to export list
Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
Russo TA, Beanan JM, Olson R, MacDonald U, Cope JJ
Vaccine, 27(3):388-395, 17 Nov 2008
Cited by: 13 articles | PMID: 19014988
Add to export list
A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.
Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR
Vaccine, 25(19):3859-3870, 05 Feb 2007
Cited by: 20 articles | PMID: 17306426 | PMCID: PMC1913199
Add to export list Free full text in Europe PMC
Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.
Russo TA, Wang Z, Davidson BA, Genagon SA, Beanan JM, Olson R, Holm BA, Knight PR, Chess PR, Notter RH
Am J Physiol Lung Cell Mol Physiol, 292(3):L632-43, 01 Mar 2007
Cited by: 15 articles | PMID: 17341765
Add to export list
E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.
Russo TA, Davidson BA, Genagon SA, Warholic NM, Macdonald U, Pawlicki PD, Beanan JM, Olson R, Holm BA, Knight PR
Am J Physiol Lung Cell Mol Physiol, 289(2):L207-16, 01 Apr 2005
Cited by: 44 articles | PMID: 15805136
Add to export list
The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Olson R, Wilding GE
Infect Immun, 71(12):7164-7169, 01 Dec 2003
Cited by: 55 articles | PMID: 14638809 | PMCID: PMC308914
Add to export list Free full text in Europe PMC
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR
Infect Immun, 70(12):7156-7160, 01 Dec 2002
Cited by: 79 articles | PMID: 12438401 | PMCID: PMC133021
Add to export list Free full text in Europe PMC
The use of monoclonal antibodies to detect Bacteroides gingivalis in biological samples.
Chen P, Bochacki V, Reynolds HS, Beanan J, Tatakis DN, Zambon JJ, Genco RJ
Infect Immun, 54(3):798-803, 01 Dec 1986
Cited by: 23 articles | PMID: 3781626 | PMCID: PMC260240
Add to export list Free full text in Europe PMC

1-25 of 25 results

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii.

Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model.

The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.

Metabolite Transporter PEG344 Is Required for Full Virulence of Hypervirulent Klebsiella pneumoniae Strain hvKP1 after Pulmonary but Not Subcutaneous Challenge.

The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.

Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.

Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.

In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.

The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model.

Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.

Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.

In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.

Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.

Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Capsule and O-antigen from an extraintestinal isolate of Escherichia coli modulate cytokine levels in rat macrophages in vitro and in a rat model of pneumonia.

Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.

A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model.

E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model.

The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.

IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.

The use of monoclonal antibodies to detect Bacteroides gingivalis in biological samples.

Partnerships & funding